Does USTEKINUMAB Cause Neuropathy peripheral? 125 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 125 reports of Neuropathy peripheral have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.2% of all adverse event reports for USTEKINUMAB.
125
Reports of Neuropathy peripheral with USTEKINUMAB
0.2%
of all USTEKINUMAB reports
1
Deaths
28
Hospitalizations
How Dangerous Is Neuropathy peripheral From USTEKINUMAB?
Of the 125 reports, 1 (0.8%) resulted in death, 28 (22.4%) required hospitalization, and 1 (0.8%) were considered life-threatening.
Is Neuropathy peripheral Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 125 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Neuropathy peripheral?
LENALIDOMIDE (10,215)
BORTEZOMIB (4,067)
OXALIPLATIN (3,662)
DEXAMETHASONE (3,543)
PACLITAXEL (3,508)
LEVOFLOXACIN (2,619)
CIPROFLOXACIN (2,607)
FLUOROURACIL (2,605)
CYCLOPHOSPHAMIDE (2,565)
POMALIDOMIDE (2,382)
Which USTEKINUMAB Alternatives Have Lower Neuropathy peripheral Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE